| [1] |
CHEN Jianuo.
Aberrant RNA alternative splicing and functional analysis in chronic lymphocytic leukemia
[J]. Basic & Clinical Medicine, 2026, 46(6): 755-764.
|
| [2] |
ZOU Binbin, CHEN Zhongyang, MA Yanni, YANG Jiabin, YU Jia.
IDH1 functions as a noncanonical RNA-binding protein to maintain differentiation blockade in acute myeloid leukemia cell line HL-60
[J]. Basic & Clinical Medicine, 2026, 46(5): 637-642.
|
| [3] |
LIU Yiyang, WANG Fang, YU Jia, LI Weiqian.
GOT2 regulates aspartate levels and viability in acute myeloid leukemia cells
[J]. Basic & Clinical Medicine, 2025, 45(5): 622-626.
|
| [4] |
CAO Jinjin, DU Juan, QU Shanna, ZHU Mingyu, WANG Yang, HU Han, LIU Binlei.
Application of multi-targeted CAR-T cell therapy in B-cell acute lymphoblastic leukemia
[J]. Basic & Clinical Medicine, 2025, 45(5): 675-680.
|
| [5] |
CHEN Xinru, TANG Jihong, XIAO Xiao, WU Yinyin, XU Huan, FENG Jun.
Clinical characteristics and prognosis of acute lymphoblastic leukemia complicated with cerebral hemorrhage in children
[J]. Basic & Clinical Medicine, 2025, 45(11): 1480-1484.
|
| [6] |
SONG Lili, GUAN Yujie, MA Ping, LI Ning.
Association between daunorubicin resistance and PD-L1 protein expression in children with acute myeloid leukemia
[J]. Basic & Clinical Medicine, 2024, 44(6): 833-839.
|
| [7] |
ZHAO Lingyan, HE Liu, MA Yanni, YU Jia.
RNA-binding protein RBPMS regulates proliferation and migration of acute myeloid leukemia cells line THP-1
[J]. Basic & Clinical Medicine, 2024, 44(5): 619-625.
|
| [8] |
ZHANG Jinfang, ZHONG Mingyan, YANG Quan, FENG Bei, LI Xingdong.
Down-regulation of ATM/hnRNPK signaling reduces adriamycin resistance of myeloid leukemia
[J]. Basic & Clinical Medicine, 2024, 44(12): 1638-1643.
|
| [9] |
.
Clinical characteristics and prognosis of acute B-lymphoblastic leukemia complicated with chemotherapy-induced peripheral neuropathy in children
[J]. Basic & Clinical Medicine, 2024, 44(10): 1394-1399.
|
| [10] |
LIU Jingwen, SONG Haoxin, ZHU Lei.
Construction and drug resistance evaluation of cell strains which stably express FIP1L1-PDGFRA protein and its mutants
[J]. Basic & Clinical Medicine, 2024, 44(1): 63-68.
|
| [11] |
ZENG Yankun, HONG Xiaoying, CHEN Qinglin.
Down-regulation of BECN1 inhibits the proliferation, invasion and migration of human leukemia cell line THP-1
[J]. Basic & Clinical Medicine, 2023, 43(7): 1104-1109.
|
| [12] |
ZHAI Xueying, WANG Fang, YU Jia.
Influence of PABPC1 on translation activity in human monocytic leukemia cell line THP-1
[J]. Basic & Clinical Medicine, 2023, 43(5): 751-754.
|
| [13] |
XIANG Caixia, HUANG Bintao, HAO Jian.
Research progress of anti-apoptotic inhibitor venetoclax in treatment of myeloid leukemia
[J]. Basic & Clinical Medicine, 2023, 43(5): 833-836.
|
| [14] |
SHU Ling, HUO Bennian, SONG Lin.
Research progress of NT5C2 in disease and treatment
[J]. Basic & Clinical Medicine, 2023, 43(5): 852-856.
|
| [15] |
LIU Yue, CAO Yang, GU Weiying, SHANG Limei, LIU Yan.
Decitabine combined with arsenic trioxide inhibits proliferation and promotes apoptosis of acute myeloid leukemia cell lines
[J]. Basic & Clinical Medicine, 2023, 43(4): 608-614.
|